Evidence map›Paper›PMID 16757738›Full record

ArticleEukaryotic cell2006

Complete cap 4 formation is not required for viability in Trypanosoma brucei.

Jesse R Zamudio, Bidyottam Mittra, Gusti M Zeiner, Marcin Feder, Janusz M Bujnicki, Nancy R Sturm, David A Campbell

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Application of Mammalian Nudix Enzymes to Capped RNA Analysis.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  3. CMTr mediated 2'-RNA (New York, N.Y.) · 2022
    Article
  4. Review
  5. Article
  6. Practical Synthesis of Cap-4 RNA.Chembiochem : a European journal of chemical biology · 2020
    Article
  7. Review
  8. The messenger RNA decapping and recapping pathway in Trypanosoma.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Kinetoplastid genomics: the thin end of the wedge.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2008
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jesse R ZamudioDepartment of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1489, USA.
Bidyottam Mittra
Gusti M Zeiner
Marcin Feder
Janusz M Bujnicki
Nancy R Sturm
David A Campbell
University of California, Los Angeles · USInternational Institute of Molecular and Cell Biology · PL

Funding

MULTIDISCIPLINARY TRAINING IN MICROBIAL PATHOGENESIST32AI007323 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peter John Bradley · 1988 to 2026
$8.6M
PREDOCTORAL TRAINING PROGRAM IN GENETIC MECHANISMS AT UCT32GM007104 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOBER, JAMES W · 1985 to 2011
$3.6M
NIAID NIH HHS 2-T32-AI-07323NIAID NIH HHS AI034056NIAID NIH HHS T32 AI007323NIGMS NIH HHS GM07104NIGMS NIH HHS T32 GM007104
6 · The paper itself

Abstract

In kinetoplastids spliced leader (SL) RNA is trans-spliced onto the 5' ends of all nuclear mRNAs, providing a universal exon with a unique cap. Mature SL contains an m(7)G cap, ribose 2'-O methylations on the first four nucleotides, and base methylations on nucleotides 1 and 4 (AACU). This structure is referred to as cap 4. Mutagenized SL RNAs that exhibit reduced cap 4 are trans-spliced, but these mRNAs do not associate with polysomes, suggesting a direct role in translation for cap 4, the primary SL sequence, or both. To separate SL RNA sequence alterations from cap 4 maturation, we have examined two ribose 2'-O-methyltransferases in Trypanosoma brucei. Both enzymes fall into the Rossmann fold class of methyltransferases and model into a conserved structure based on vaccinia virus homolog VP39. Knockdown of the methyltransferases individually or in combination did not affect growth rates and suggests a temporal placement in the cap 4 formation cascade: TbMT417 modifies A(2) and is not required for subsequent steps; TbMT511 methylates C(3), without which U(4) methylations are reduced. Incomplete cap 4 maturation was reflected in substrate SL and mRNA populations. Recombinant methyltransferases bind to a methyl donor and show preference for m(7)G-capped RNAs in vitro. Both enzymes reside in the nucleoplasm. Based on the cap phenotype of substrate SL stranded in the cytosol, A(2), C(3), and U(4) methylations are added after nuclear reimport of Sm protein-complexed substrate SL RNA. As mature cap 4 is dispensable for translation, cap 1 modifications and/or SL sequences are implicated in ribosomal interaction.

Indexed as

Amino Acid SequenceAnimalsCell NucleusMethylationMethyltransferasesMolecular Sequence DataRecombinant Fusion ProteinsRNA CapsRNA InterferenceRNA, MessengerRNA, ProtozoanRNA, Spliced LeaderSequence AlignmentSubstrate SpecificityTrypanosoma brucei bruceiMethyltransferasesmRNA (nucleoside-O(2'))-methyltransferaseRecombinant Fusion ProteinsRNA CapsRNA, MessengerRNA, ProtozoanRNA, Spliced Leader

Identifiers

PMID16757738
PMCPMC1489268
OpenAlexW2111720133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.